State of Delaware
Secre of State
Division of Corporations
Delivered 11:31 08/17/2010
FILED 11:17 AM 08/17/2010
SRV 100834137 - 3795144 FILE

CERTIFICATE OF AMENDMENT
TO
THE AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
AXIOMED SPINE CORPORATION

AxioMed Spine Corporation (the "Corporation"), a corporation organized and existing under and by
virtue of the Delaware General Corporation f.aw, hereby certifies as follows:

1. ‘That by written action without a meeting, pursuant to Sections 141(f} and 242 of the Delaware
General Corporation Law (the "DGCL"), the Board of Directors of the Corporation duly adopted resolutions
setting forth the terms of this proposed Certificate of Amendment to the Corporation's Amended and Restated
Certificate of Incorporation dated July 16, 2010 (the “Existing Certificate"), declaring said amendment to be
advisable and calling for its consideration by the stockholders of the Corporation.

2. ‘That thereafter, pursuant to DGCL Section 228, a written consent in lieu of a meeting of the
stockholders of the Corporation was executed by stockholders holding at least a majority in interest of the
oulstanding stock of the Corporation, which written consent approved this Certificate of Amendment to the
Existing Certificate.

3. Pursuant to DGCL Section 242, this Certificate of Amendment hereby amends the provisions of
the Existing Certificate by deleting the first paragraph of Article FOURTH] in its entirety and replacing it with the
following:

“The maximum number of shares of capital stock which the Corporation is authorized to have outstanding
is 160,841,322 shares, 91,300,756 shares of which shall be Common Stock, par value $0.001 per share (the
"Common Stock"), consisting of 91,196,590 shares of Class A Common Stock (the "Class A Common Stock")
and 104,166 shares of Class B Common Stock (the "Class B Common Stock”), and 69,540,566 shares of which
shall be Preferred Stock, par value $0.00! per share, 6,550,000 of which shall be designated Series A Preferred
Stock (the "Series A Preferred Stock"). 21,538,462 of which shall be designated Series B Preferred Stock (the
"Series B Preferred Stock"), 9,451,495 of which shall be designated Series C Preferred Stock (the "Series C
Preferred Stock"). and 32,000,609 of which shall be designated Series D Preferred Stock (the “Series D Preferred
Stock" and, together with the Series A Preferred Stock, the Series B Preferred Stock, and the Series C Preferred
Stock, the "Preferred Stock"). The Class A Common Stock and the Class B Common Stock shall be identical in
all respects, except that only the Class A Common Stock shall have voting rights.”

4, This Certificate of Amendment to the Corporation's Amended and Restated Certificate of

Incorporation dated July 16, 2010 was duly adopted in accordance with the provisions of Section 242 of the
DGCL.

[intentionally left blank; signature page follows]
Auge. 14. 2010 10:45AM No. 7016 PL 3

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed this 17th
day of August, 2010.

AXIOMED SPINE CORPORATION

Title: President and Chief Executive Officer

taantn

Se ScSnSSSSSSSSSSereeeee
